Polomar Health Services, Inc.
Close on Oct 19, 2026
- Market cap
- $3.37M
- P/E (TTM)
- –
- Dividend yield
- –
About Polomar Health Services
Pharmaceutical Preparations, SIC 2834
Polomar Health Services, Inc. operates a retail compounding pharmacy business through its subsidiary, Polomar Specialty Pharmacy, LLC. The company specializes in manufacturing and dispensing custom prescription formulations, including dermatological topical treatments and sterile injectable GLP-1 receptor agonists used for weight management, alongside erectile dysfunction medications. In addition to compounding sterile injectables on-site, it sources non-sterile inhaled and sublingual drug formulations from contract manufacturers and outsourcing facilities. The business serves patients directly through healthcare provider prescriptions and provides wholesale fulfillment services to third-party telehealth platforms. It also plans to market weight loss therapies through its proprietary online platform, SlimRx.
The company operates an authorized compounding pharmacy facility located in Palm Harbor, Florida, where it maintains sterile clean room capabilities. It holds licenses and regulatory authorizations to fulfill and dispense prescription medications to customers across 28 U.S. states. Polomar Health Services is headquartered in Palm Harbor, Florida.
Summary of the business section of Polomar Health Services's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Polomar Health Services, Inc.
- Founded
- 2000
- Headquarters
- Palm Harbor, FL
- Address
- 32866 Us Hwy. 19 N 34684
- Phone
- (800) 490-7454
- Website
- slimrx.com
- Employees
- 6, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- GreenGrowth CPAs, Los Angeles, California
Stock & identifiers
- Ticker
- PMHS
- Exchange
- OTC
- Shares outstanding
- 28M, Aug 10, 2026
- Public float
- $3.61M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-10 reverse, Nov 1, 2024; 1-for-2000 reverse, Sep 2, 2022; 30-for-1, Jun 10, 2010
- SEC CIK
- 1265521
- EIN
- 86-1006313
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Terrence McGill Tierney | President, Director | 141,028 |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we have six full time employees, and two part time employees.”
Corporate history
Events identified from SEC filings